Squamous cell carcinoma of the anal canal

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Squamous cell carcinoma of the anal canal.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Squamous cell carcinoma of the anal canal.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Zynyz

(retifanlimab-dlwr)Orphan drugstandard

Incyte Corporation

Programmed Death Receptor-1 Blocking Antibody [EPC]

12.1 Mechanism of Action Binding of the PD-1 ligands, PD-L1 and PD-L2, to the PD-1 receptor found on T cells, inhibits T-cell proliferation and cytoki...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Squamous cell carcinoma of the anal canal.
Search all trials →
Search clinical trials for Squamous cell carcinoma of the anal canal

Recent News & Research

No recent news articles indexed yet for Squamous cell carcinoma of the anal canal.
Search PubMed for Squamous cell carcinoma of the anal canal

Browse all Squamous cell carcinoma of the anal canal news →

Specialist Network

Top 6 by expertise

View all Squamous cell carcinoma of the anal canal specialists →

Quick Actions